Lot-Matched CoAs Published
Research Use Only · Not For Human Consumption
Same-Day Dispatch from Manchester
Independently Tested · Accredited External Lab
Stored at −20°C Until Dispatch
Home/Buy/Retatrutide 20mg
Retatrutide 20mg vial
Retatrutide 20mg vial

Metabolic Research

Retatrutide 20mg

The same retatrutide (LY3437943) as our 10mg vial — twice the payload from one lot, at a lower cost per milligram. Signed batch CoA on the page.

Vial size

Quantity

£89.99

In stock

Inc. VAT · Free UK shipping on this order

Order within 14min 50s for same-day dispatchPay by Bank · approved in your banking appBarclaysHSBCLloydsNatWestSantanderMonzo+ more
Delivery.
Free UK shipping, Royal Mail Tracked 24. Same-day before 6pm. Details
Payment.
Pay by Bank — approved with Face ID in your banking app, in seconds. No card details, no account to create.
Returns.
14 days if unopened and sealed. Faulty or wrong items replaced free. Policy

Certificate of Analysis

Retatrutide 20mg

Batch number
UKP-RETA20-2512

Handling

Storage

Sealed vial
-20°C, protect from light
Once reconstituted
Once reconstituted, store at 2–8°C (refrigerated). Use within 28 days.
Diluent
Bacteriostatic water (0.9% benzyl alcohol)
Shipping
Royal Mail Tracked 24
+ Add Bacteriostatic Water (£1.99) →
FAQ

Retatrutide 20mg — common questions

6 more questions
Research Compound

About Retatrutide

The 20mg presentation of retatrutide (LY3437943). A synthetic 39-residue triple agonist at the GLP-1, GIP and glucagon receptors. The synthesis route, the ≥98% HPLC-UV specification and the independent laboratories are the same as the 10mg vial. What differs is the fill weight, the rate per milligram and how long one lot number lasts.

More about this listing

The signed third-party certificate for this lot is published on this product page. This page is the 20mg fill specifically. Searching for retatrutide generally? The Retatrutide 10mg vial is our standard listing and the cheaper entry point. For a study long enough that a lot change would become a variable, the Retatrutide 30mg exists for that.

Research areas

  • Extended GPCR signalling time-courses
  • Multi-condition receptor pharmacology
  • Long-duration adipocyte and hepatocyte assays
  • Analytical method development
Five UK Peptides vials in an open presentation box

The range

One vial, or the set.

Every vial in the range is lyophilised, labelled and lot-numbered the same way, with the certificate for its lot linked from its own product page. Pictured: BPC-157, TB-500, GHK-Cu, Glow and Retatrutide.

Browse the range
Compound Profile

Technical profile

Read the full Retatrutide technical profile7 sections

Retatrutide 20mg — also searched as "Reta 20mg" — is the extended fill of Eli Lilly's investigational triple GLP-1/GIP/glucagon receptor agonist, LY3437943. Same synthesis, same ≥98% HPLC-UV specification and the same signed third-party Certificate of Analysis practice as the 10mg vial, with twice the payload on one lot number and a lower cost per milligram for laboratories running longer in-vitro protocols.

Retatrutide is investigational: it holds no MHRA, EMA or FDA marketing authorisation and cannot be prescribed or dispensed in the United Kingdom. Supplied for in-vitro and preclinical laboratory research only, dispatched same day from Manchester.

01

Retatrutide 20mg UK — the extended fill

This page lists the Retatrutide 20mg vial specifically: double the peptide payload of our standard listing, from a single lot, for laboratories running longer in-vitro protocols. "Reta" is the shorthand researchers use for retatrutide (LY3437943). If you are searching more generally for retatrutide rather than for this fill size, our Retatrutide 10mg vial is the standard listing you are looking for — the same synthesis, the same ≥98% HPLC specification, the same third-party certificate, at the smaller fill and the lower vial price.

If your protocol runs long enough that a lot change partway through would become a variable you have to control for, the Retatrutide 30mg is the single-lot option. All three are supplied as sealed vials of lyophilised powder that the researcher reconstitutes; there is no other presentation of retatrutide in this catalogue.

02

Retatrutide 20mg: the extended-protocol fill

The 20mg presentation doubles the peptide payload per vial without changing any aspect of synthesis, purity specification or third-party verification. What it changes is arithmetic: twice the working volume at the same reconstitution concentration, one lot number covering twice as much work, one certificate to file instead of two, and a lower cost per milligram.

It is the fill for multi-week receptor pharmacology, concentration–response series within a single arm, or extended adipocyte and hepatocyte assays where consolidating lot handling reduces analytical noise and cost per data point. What it does not change is the material: a 20mg vial is the same compound at the same specification as a 10mg vial, in a larger fill.

03

In-vitro research applications for the 20mg fill

The 20mg vial supports roughly twice the protocol duration of the 10mg at identical reconstitution concentrations. Typical use cases include:

  • Extended GPCR signalling cascades (cAMP, β-arrestin, ERK1/2)
  • Comparative pharmacology against tirzepatide and semaglutide
  • Long-duration adipocyte differentiation studies in culture
  • Receptor-ratio and biased-signalling characterisation
  • Hepatic stellate and hepatocyte glucose-output models
  • Analytical stability work on fatty-acid-modified peptides
04

Storage and stability

Store the lyophilised vial at -20°C in its sealed container, protected from light and moisture, and allow it to reach room temperature before opening so condensation cannot enter the vial.

A lipidated peptide is prone to denaturing at an air–liquid interface, so foaming matters here more than it would for a short unmodified sequence. Refrigerate the reconstituted solution at 2–8°C and use within 28 days; do not refreeze. These are solvent volumes for putting powder into solution, not doses.

05

Third-party verified purity and lot traceability

Every Retatrutide 20mg vial dispatched is covered by a signed PDF Certificate of Analysis from an accredited independent laboratory, covering HPLC-UV purity (≥98%), mass-spectrometry identity, residual solvents and visual inspection. The certificate published on this page corresponds to the exact lot you will receive, it is indexed on our lab reports page, and the lot number on the vial and the lot on the certificate always match.

One caution belongs with it: retatrutide has no resolvable PubChem record, the CID widely circulated for it returns tirzepatide, and the mass usually quoted for it is reported rather than verified. Read the mass from the certificate for your lot and check it by mass spectrometry rather than against a published reference figure.

06

Choosing between the 10mg, 20mg and 30mg fills

The three fills are the same compound, the same synthesis route and the same ≥98% HPLC-UV specification. What differs is the fill weight, the rate per milligram and how long one lot number lasts. The 10mg is the entry vial and our standard listing, at £49.99 or £5.00 per milligram.

This 20mg vial is £89.99, or £4.50 per milligram, and suits an extended single-arm protocol. The 30mg is £124.99, or £4.17 per milligram — it holds the lowest per-milligram figure of the three, not this vial — and it exists for studies long enough that a lot change would otherwise become a variable to control for.

All prices are per vial; there is no monthly or course price for any fill, because a monthly figure would presuppose a person on a schedule. One point of difference worth knowing before ordering: the 10mg and 20mg lots each have a signed certificate published on their product page, and the 30mg lot's is not yet published.

The prices on each product page are authoritative if this section ever falls behind them.

07

Why buy Retatrutide 20mg from UK Peptides

UK Peptides is a UK-stocked, UK-dispatched research peptide supplier with a registered UK address behind the sale — no overseas customs step, no grey-market sourcing, no anonymous fulfilment. Same-day dispatch on orders placed before 6pm GMT on a working day, Royal Mail Tracked 24, and a signed third-party certificate published on the page for the lot in the box.

What we are not is equally clear: not a pharmacy, not a prescriber, not a clinic. We supply lyophilised research material, and nothing in this catalogue is sold as a treatment.

References & further reading

Primary sources cited on this page

Sources & related pages5 sources · 13 related

It is investigational and unlicensed: no MHRA, EMA or FDA marketing authorisation exists. The Phase 2 papers listed below report outcomes in people enrolled in clinical trials and are cited as the primary literature for the compound, not as evidence of anything about material supplied for laboratory use.

Regulatory & compliance notice

This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.

Last reviewed 22 July 2026.

Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.

Third-party HPLC-UV testing Lot-matched CoA on every order Batch-traceable from dispatch

Legal notice

This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.

Retatrutide 20mg

£89.99